BIVRX vs. USNQX
Compare and contrast key facts about Invenomic Fund (BIVRX) and USAA Nasdaq 100 Index Fund (USNQX).
BIVRX is managed by Invenomic. It was launched on Jun 18, 2017. USNQX is managed by Victory Capital. It was launched on Oct 27, 2000.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BIVRX or USNQX.
Performance
BIVRX vs. USNQX - Performance Comparison
Returns By Period
In the year-to-date period, BIVRX achieves a -12.53% return, which is significantly lower than USNQX's 23.27% return.
BIVRX
-12.53%
1.20%
-5.11%
-24.43%
8.54%
N/A
USNQX
23.27%
1.53%
10.69%
27.63%
17.94%
16.03%
Key characteristics
| BIVRX | USNQX | |
|---|---|---|
| Sharpe Ratio | -1.33 | 1.53 |
| Sortino Ratio | -1.58 | 2.08 |
| Omega Ratio | 0.72 | 1.28 |
| Calmar Ratio | -0.72 | 1.98 |
| Martin Ratio | -1.12 | 7.16 |
| Ulcer Index | 21.94% | 3.75% |
| Daily Std Dev | 18.53% | 17.59% |
| Max Drawdown | -34.31% | -74.36% |
| Current Drawdown | -32.88% | -2.13% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
BIVRX vs. USNQX - Expense Ratio Comparison
BIVRX has a 2.48% expense ratio, which is higher than USNQX's 0.42% expense ratio.
Correlation
The correlation between BIVRX and USNQX is -0.10. This indicates that the assets' prices tend to move in opposite directions. Negative correlation can be particularly beneficial for diversification and risk management, as one asset may offset the losses of the other during market fluctuations.
Risk-Adjusted Performance
BIVRX vs. USNQX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Invenomic Fund (BIVRX) and USAA Nasdaq 100 Index Fund (USNQX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
BIVRX vs. USNQX - Dividend Comparison
BIVRX's dividend yield for the trailing twelve months is around 3.00%, more than USNQX's 0.47% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BIVRX Invenomic Fund | 3.00% | 2.62% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
USNQX USAA Nasdaq 100 Index Fund | 0.47% | 0.58% | 0.28% | 0.24% | 0.37% | 0.55% | 0.65% | 0.46% | 0.50% | 0.62% | 0.21% | 0.28% |
Drawdowns
BIVRX vs. USNQX - Drawdown Comparison
The maximum BIVRX drawdown since its inception was -34.31%, smaller than the maximum USNQX drawdown of -74.36%. Use the drawdown chart below to compare losses from any high point for BIVRX and USNQX. For additional features, visit the drawdowns tool.
Volatility
BIVRX vs. USNQX - Volatility Comparison
The current volatility for Invenomic Fund (BIVRX) is 3.01%, while USAA Nasdaq 100 Index Fund (USNQX) has a volatility of 5.62%. This indicates that BIVRX experiences smaller price fluctuations and is considered to be less risky than USNQX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.